Geron Corporation GERN
$ 3.34
0.0%
Quarterly report 2024-Q3
added 11-07-2024
Country |
USA |
IPO year |
1996 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. John Scarlett |
Employees in the company |
45 |
Shares |
571 M |
Market Cap[1] |
$ 1.91 B |
EBITDA (LTM) |
$ -164 M |
P/E (LTM) |
-13.84 |
P/S (LTM) |
82.65 |
EPS (LTM) |
-0.31 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.